Coronavirus: biontech ready for delivery first vaccine boxes in the eu

The Mainz company BIONTECH and the US Pharmaceutical company Pfizer are according to own information on the delivery of the first vaccines to the EU in the starting pages. "We are ready to start the delivery of the first vaccine boxes in the EU as soon as we get grunes light", said Biontech boss and coarse Ugur Sahin on Monday.

Previously, the European Pharmaceutical Agency (EMA) had recommended the inclusion of the first Corona vaccine, which is to be distributed under the trade name Comirnaty. As the EMA notified, sufficiently resilient data on the quality, safety and efficacy of Comirnaty are available to recommend a formally conditional approval for placing on the market. The approximately 44.000 Participant Clinical Study had shown the effectiveness of the vaccine in people over 16 years in an efficiency of 95 percent.

In line with the EU safety monitoring plan for Covid-19 vaccines, Comirnaty will monitor to pursue potential side effects in vaccinating millions of people. Additional studies on the vaccine should also be made. The EMA sees the vaccine as a milestone for the evidence of the coronavirus pandemic. At the same time, however, the EMA set up that this is not a turning point in the pandemic.

At the moment of the vaccine still expected today

In a next step, the EU Commission now has to decide on the total vaccine for all member standards. However, this is considered a pure formality. According to the EU Commission Prospective, Ursula von der Leyen, is the decision on Monday, she shared on Twitter. An impressive start with Comirnaty was already at the 27.12.2020 take place.

"Today’s decision is a particularly personal and emotional for us all at Biiontech", Clarified Sahin. "As a company based in the heart of the EU, we are particularly pleased to be a step closer to deliver the first vaccine against this devastating pandemic in Europe."